894 related articles for article (PubMed ID: 24412895)
21. Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.
Ørnbjerg LM; Østergaard M; Jensen T; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Hetland ML; ; Slot O; Nielsen LK; Skjødt H; Majgaard O; Lorenzen T; Horn HC; Kowalski M; Johansen IL; Pedersen PM; Manilo N; Bliddal H
Clin Rheumatol; 2017 Apr; 36(4):781-789. PubMed ID: 27921185
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance imaging for accelerated assessment of drug effect and prediction of subsequent radiographic progression in rheumatoid arthritis: a study of patients receiving combined anakinra and methotrexate treatment.
Østergaard M; Duer A; Nielsen H; Johansen JS; Narvestad E; Ejbjerg BJ; Baslund B; Møller JM; Thomsen HS; Petersen J
Ann Rheum Dis; 2005 Oct; 64(10):1503-6. PubMed ID: 15778238
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic quality and scoring of synovitis, tenosynovitis and erosions in low-field MRI of patients with rheumatoid arthritis: a comparison with conventional MRI.
Schirmer C; Scheel AK; Althoff CE; Schink T; Eshed I; Lembcke A; Burmester GR; Backhaus M; Hamm B; Hermann KG
Ann Rheum Dis; 2007 Apr; 66(4):522-9. PubMed ID: 17068069
[TBL] [Abstract][Full Text] [Related]
24. Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study.
Palosaari K; Vuotila J; Takalo R; Jartti A; Niemelä RK; Karjalainen A; Haapea M; Soini I; Tervonen O; Hakala M
Rheumatology (Oxford); 2006 Dec; 45(12):1542-8. PubMed ID: 16670155
[TBL] [Abstract][Full Text] [Related]
25. Early prediction of rheumatoid arthritis by magnetic resonance imaging in the absence of anti-cyclic citrullinated peptide antibodies and radiographic erosions in undifferentiated inflammatory arthritis patients: a prospective study.
Ji L; Li G; Xu Y; Zhou W; Zhang Z
Int J Rheum Dis; 2015 Nov; 18(8):859-65. PubMed ID: 25483781
[TBL] [Abstract][Full Text] [Related]
26. No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial.
Poggenborg RP; Wiell C; Bøyesen P; Boonen A; Bird P; Pedersen SJ; Sørensen IJ; Madsen OR; Slot O; Møller JM; Hasselquist M; Kubassova O; Østergaard M
Rheumatology (Oxford); 2014 Apr; 53(4):746-56. PubMed ID: 24369412
[TBL] [Abstract][Full Text] [Related]
27. Modern treatment strategies in rheumatoid arthritis.
Hetland ML
Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935
[TBL] [Abstract][Full Text] [Related]
28. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis.
Conaghan PG; O'Connor P; McGonagle D; Astin P; Wakefield RJ; Gibbon WW; Quinn M; Karim Z; Green MJ; Proudman S; Isaacs J; Emery P
Arthritis Rheum; 2003 Jan; 48(1):64-71. PubMed ID: 12528105
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI.
Suzuki T; Horikoshi M; Sugihara M; Hirota T; Ogishima H; Umeda N; Kondo Y; Tsuboi H; Hayashi T; Chino Y; Matsumoto I; Sumida T
Mod Rheumatol; 2013 Jul; 23(4):782-7. PubMed ID: 22975733
[TBL] [Abstract][Full Text] [Related]
30. MRI and Dose Selection in a Phase II Trial of Baricitinib with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis.
Peterfy C; DiCarlo J; Emery P; Genovese MC; Keystone EC; Taylor PC; Schlichting DE; Beattie SD; Luchi M; Macias W
J Rheumatol; 2019 Aug; 46(8):887-895. PubMed ID: 30647190
[TBL] [Abstract][Full Text] [Related]
31. Intra-articular methotrexate in knee synovitis.
Hasso N; Maddison PJ; Breslin A
Rheumatology (Oxford); 2004 Jun; 43(6):779-82. PubMed ID: 15054155
[TBL] [Abstract][Full Text] [Related]
32. Synovial inflammation assessed by ultrasonography correlates with MRI-proven osteitis in patients with rheumatoid arthritis.
Kawashiri SY; Suzuki T; Nakashima Y; Horai Y; Okada A; Nishino A; Iwamoto N; Ichinose K; Arima K; Tamai M; Nakamura H; Origuchi T; Uetani M; Aoyagi K; Eguchi K; Kawakami A
Rheumatology (Oxford); 2014 Aug; 53(8):1452-6. PubMed ID: 24659755
[TBL] [Abstract][Full Text] [Related]
33. Osteitis and synovitis, but not bone erosion, is associated with proteoglycan loss and microstructure damage in the cartilage of patients with rheumatoid arthritis.
Herz B; Albrecht A; Englbrecht M; Welsch GH; Uder M; Renner N; Schlechtweg P; Paul D; Lauer L; Engelke K; Janka R; Rech J; Schett G; Finzel S
Ann Rheum Dis; 2014 Jun; 73(6):1101-6. PubMed ID: 23625980
[TBL] [Abstract][Full Text] [Related]
34. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcome and imaging changes after intraarticular (IA) application of etanercept or methylprednisolone in rheumatoid arthritis: magnetic resonance imaging and ultrasound-Doppler show no effect of IA injections in the wrist after 4 weeks.
Boesen M; Boesen L; Jensen KE; Cimmino MA; Torp-Pedersen S; Terslev L; Koenig M; Danneskiold-Samsøe B; Røgind H; Bliddal H
J Rheumatol; 2008 Apr; 35(4):584-91. PubMed ID: 18322991
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of magnetic resonance imaging-detected tenosynovitis in the hand and wrist in early arthritis.
Nieuwenhuis WP; Krabben A; Stomp W; Huizinga TW; van der Heijde D; Bloem JL; van der Helm-van Mil AH; Reijnierse M
Arthritis Rheumatol; 2015 Apr; 67(4):869-76. PubMed ID: 25510520
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression.
Haavardsholm EA; Bøyesen P; Østergaard M; Schildvold A; Kvien TK
Ann Rheum Dis; 2008 Jun; 67(6):794-800. PubMed ID: 17981915
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoring.
Beals C; Baumgartner R; Peterfy C; Balanescu A; Mirea G; Harabagiu A; Popa S; Cheng A; Feng D; Ashton E; DiCarlo J; Vallee MH; Dardzinski BJ
PLoS One; 2017; 12(12):e0187397. PubMed ID: 29236711
[TBL] [Abstract][Full Text] [Related]
39. Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab.
Klarenbeek NB; Güler-Yüksel M; van der Heijde DM; Hulsmans HM; Kerstens PJ; Molenaar TH; de Sonnaville PB; Huizinga TW; Dijkmans BA; Allaart CF
Ann Rheum Dis; 2010 Dec; 69(12):2107-13. PubMed ID: 20610442
[TBL] [Abstract][Full Text] [Related]
40. MRI comes of age in RA clinical trials.
Peterfy C; Østergaard M; Conaghan PG
Ann Rheum Dis; 2013 Jun; 72(6):794-6. PubMed ID: 23345597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
